Missed NVDA?
Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
CLVT Stock Forecast 2026-2027
$2.78
Current Price
$1.78B
Market Cap
Buy 2
Hold 6
Sell 1
Wall St Analyst Ratings
Distance to CLVT Price Targets
+115.8%
To High Target of $6.00
+4.3%
To Median Target of $2.90
-13.7%
To Low Target of $2.40
CLVT Price Momentum
-1.1%
1 Week Change
+28.1%
1 Month Change
-35.5%
1 Year Change
-16.8%
Year-to-Date Change
-41.7%
From 52W High of $4.77
+67.5%
From 52W Low of $1.66
📊 TOP ANALYST CALLS
Did CLVT Make This Month's Elite Buy List?
We don't follow just any analyst — only the top 3% with a proven track record make our cut. See if Clarivate is one of their latest high-conviction picks.
Latest CLVT Stock Price Targets & Analyst Predictions
Based on our analysis of 12 Wall Street analysts, CLVT has a neutral consensus with a median price target of $2.90 (ranging from $2.40 to $6.00). The overall analyst rating is Buy (6.7/10). Currently trading at $2.78, the median forecast implies a 4.3% upside. This outlook is supported by 2 Buy, 6 Hold, and 1 Sell ratings.
The most optimistic forecast comes from Ashish Sabadra at RBC Capital, projecting a 115.8% upside. Conversely, the most conservative target is provided by Manav Patnaik at Barclays, suggesting a 13.7% downside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
CLVT Analyst Ratings
2
Buy
6
Hold
1
Sell
CLVT Price Target Range
Low
$2.40
Average
$2.90
High
$6.00
Current: $2.78
Latest CLVT Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for CLVT.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Mar 4, 2026 | Citigroup | Peter Christiansen | Neutral | Maintains | $2.80 |
| Feb 25, 2026 | RBC Capital | Ashish Sabadra | Sector Perform | Maintains | $3.00 |
| Feb 25, 2026 | Barclays | Manav Patnaik | Underweight | Maintains | $2.40 |
| Jan 8, 2026 | Goldman Sachs | George Tong | Neutral | Downgrade | $3.60 |
| Dec 17, 2025 | Morgan Stanley | Toni Kaplan | Underweight | Downgrade | $3.00 |
| Sep 3, 2025 | Wolfe Research | Scott Wurtzel | Peer Perform | Initiates | $N/A |
| Jul 18, 2025 | Jefferies | Surinder Thind | Hold | Downgrade | $4.50 |
| Feb 20, 2025 | RBC Capital | Ashish Sabadra | Sector Perform | Reiterates | $6.00 |
| Nov 7, 2024 | Barclays | Manav Patnaik | Underweight | Maintains | $4.00 |
| Nov 7, 2024 | RBC Capital | Ashish Sabadra | Sector Perform | Maintains | $6.00 |
| Nov 6, 2024 | William Blair | Andrew Nicholas | Market Perform | Downgrade | $N/A |
| Aug 7, 2024 | RBC Capital | Ashish Sabadra | Sector Perform | Maintains | $7.00 |
| Aug 7, 2024 | Barclays | Manav Patnaik | Underweight | Maintains | $5.00 |
| May 9, 2024 | Goldman Sachs | George Tong | Buy | Maintains | $7.50 |
| Feb 28, 2024 | Barclays | Manav Patnaik | Underweight | Maintains | $6.00 |
| Feb 28, 2024 | RBC Capital | Ashish Sabadra | Sector Perform | Maintains | $8.00 |
| Feb 28, 2024 | Oppenheimer | Owen Lau | Outperform | Maintains | $10.00 |
| Feb 28, 2024 | Morgan Stanley | Toni Kaplan | Equal-Weight | Maintains | $8.00 |
| Jan 8, 2024 | Oppenheimer | Owen Lau | Outperform | Maintains | $11.00 |
| Dec 15, 2023 | Wells Fargo | Seth Weber | Underweight | Downgrade | $8.00 |
Clarivate Plc (CLVT) Competitors
The following stocks are similar to Clarivate based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Clarivate Plc (CLVT) Financial Data
Clarivate Plc has a market capitalization of $1.78B with a P/E ratio of 30.8x. The company generates $2.45B in trailing twelve-month revenue with a -5.6% profit margin.
Revenue growth is -1.4% quarter-over-quarter, while maintaining an operating margin of +5.1% and return on equity of -2.8%.
Valuation Metrics
Market Cap
$1.78B
Enterprise Value
$5.88B
P/E Ratio
30.8x
PEG Ratio
-0.5x
Price/Sales
0.7x
Growth & Margins
Revenue Growth (YoY)
-1.4%
Gross Margin
+67.2%
Operating Margin
+5.1%
Net Margin
-5.6%
EPS Growth
-1.4%
Financial Health
Cash/Price Ratio
+13.1%
Current Ratio
0.8x
Debt/Equity
90.5x
ROE
-2.8%
ROA
+1.0%
💡 SKIP THE NOISE
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings — tracked and updated every Monday and Thursday.
Clarivate Plc (CLVT) Business Model
About Clarivate Plc
What They Do
Provides analytics and information solutions.
Business Model
Clarivate Plc operates by offering comprehensive intellectual property and scientific information solutions to various sectors, including legal, pharmaceutical, biotechnology, academic, and financial industries. The company generates revenue through subscription services, data licensing, and analytics tools that help clients make informed decisions using high-quality data.
Additional Information
Notable products include the Web of Science research database and Derwent patent information services. Clarivate's role is crucial in navigating complex information ecosystems, enhancing productivity, and fostering innovation in an increasingly data-driven world.
Company Information
Sector
Technology
Industry
Information Technology Services
Employees
12,000
CEO
Mr. Matitiahu Shem Tov
Country
United Kingdom
IPO Year
2006
Website
www.clarivate.comClarivate Plc (CLVT) Latest News & Analysis
Latest News
Quick Summary
Clarivate Plc has launched the Web of Science Research Intelligence platform globally, aimed at enhancing decision-making in research funding and strategy for institutions.
Why It Matters
The global launch of Clarivate's AI-native research platform enhances its market position, potentially increasing demand for its services and boosting revenue, making CLVT a more attractive investment.
Source: PRNewsWire
Market Sentiment:
Neutral
Quick Summary
Clarivate Plc (CLVT) held its Q1 2026 earnings call, discussing financial performance and strategic initiatives. Detailed earnings results and future outlook were shared.
Why It Matters
Clarivate Plc's Q1 2026 earnings call reveals financial performance and future outlook, influencing stock valuation and investor sentiment regarding growth potential and risk.
Source: Seeking Alpha
Market Sentiment:
Neutral
Clarivate Reports First Quarter 2026 Results
12 days ago
Quick Summary
Clarivate Plc reported strong first-quarter results for 2026, highlighting accelerated organic revenue growth, effective cash flow management for deleveraging, and reaffirmed its 2026 financial outlook.
Why It Matters
Accelerated organic revenue growth and solid free cash flow indicate strong financial health for Clarivate, enhancing investor confidence and supporting its 2026 outlook.
Source: PRNewsWire
Market Sentiment:
Neutral
Quick Summary
Clarivate (CLVT) reported its revenue and EPS for Q1 2026. Key metrics should be evaluated against Wall Street estimates and year-ago performance for a comprehensive assessment.
Why It Matters
Clarivate's revenue and EPS performance relative to Wall Street estimates and year-ago figures can signal growth potential or weaknesses, influencing investor sentiment and stock valuation.
Source: Zacks Investment Research
Market Sentiment:
Positive
Quick Summary
Clarivate PLC (CLVT) reported Q3 earnings of $0.18 per share, surpassing the Zacks Consensus Estimate of $0.14 and up from $0.14 per share year-over-year.
Why It Matters
Clarivate's earnings beat expectations, indicating stronger financial performance and potential growth. This may boost investor confidence and positively impact the stock price.
Source: Zacks Investment Research
Market Sentiment:
Positive
Clarivate Introduces Nexus Connect, the First Institutional AI Gateway to Trusted Research and Learning
13 days ago
Quick Summary
Clarivate Plc has launched Nexus Connect, an AI connector for universities, enhancing student and researcher access to academic resources and services.
Why It Matters
Nexus Connect enhances academic access through AI, potentially increasing Clarivate's market share and revenue from educational institutions, positively impacting stock performance.
Source: PRNewsWire
Market Sentiment:
Neutral
Frequently Asked Questions About CLVT Stock
What is Clarivate Plc's (CLVT) stock forecast for 2026?
Based on our analysis of 12 Wall Street analysts, Clarivate Plc (CLVT) has a median price target of $2.90. The highest price target is $6.00 and the lowest is $2.40.
Is CLVT stock a good investment in 2026?
According to current analyst ratings, CLVT has 2 Buy ratings, 6 Hold ratings, and 1 Sell ratings. The stock is currently trading at $2.78. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for CLVT stock?
Wall Street analysts predict CLVT stock could reach $2.90 in the next 12 months. This represents a 4.3% increase from the current price of $2.78. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is Clarivate Plc's business model?
Clarivate Plc operates by offering comprehensive intellectual property and scientific information solutions to various sectors, including legal, pharmaceutical, biotechnology, academic, and financial industries. The company generates revenue through subscription services, data licensing, and analytics tools that help clients make informed decisions using high-quality data.
What is the highest forecasted price for CLVT Clarivate Plc?
The highest price target for CLVT is $6.00 from Ashish Sabadra at RBC Capital, which represents a 115.8% increase from the current price of $2.78.
What is the lowest forecasted price for CLVT Clarivate Plc?
The lowest price target for CLVT is $2.40 from Manav Patnaik at Barclays, which represents a -13.7% decrease from the current price of $2.78.
What is the overall CLVT consensus from analysts for Clarivate Plc?
The overall analyst consensus for CLVT is neutral. Out of 12 Wall Street analysts, 2 rate it as Buy, 6 as Hold, and 1 as Sell, with a median price target of $2.90.
How accurate are CLVT stock price projections?
Stock price projections, including those for Clarivate Plc, are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: May 11, 2026 2:27 AM UTC